Disgusting for a public company. Appears to be no consensus view on how to move this drug forward and management infighting has caused delays and irreparable damage to the company and its prospects.
while a prefer a management team with skin in the game there are plenty of examples where this a problem and they can’t see the forest through the trees.
get on with it I say, I’d expect DT to at least explain what the issues were with DCB and the new strategy. Hard to see how he isn’t behind these changes.
Ann: Race Board and Management Team Changes, page-76
-
- There are more pages in this discussion • 375 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.55 |
Change
0.085(5.80%) |
Mkt cap ! $264.2M | |||
| Open | High | Low | Value | Volume |
| $1.50 | $1.55 | $1.49 | $246.4K | 163.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $1.54 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.55 | 5483 | 2 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |